CRIS Current Research Information System

GIANNINI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.611
AS - Asia 5.312
EU - Europa 2.661
SA - Sud America 345
AF - Africa 226
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.571
SG - Singapore 1.852
CN - Cina 1.250
VN - Vietnam 795
HK - Hong Kong 707
DE - Germania 703
GB - Regno Unito 525
IN - India 366
IT - Italia 289
SE - Svezia 259
BR - Brasile 252
RU - Federazione Russa 212
KR - Corea 174
IE - Irlanda 165
FR - Francia 151
TG - Togo 108
NL - Olanda 85
AT - Austria 67
AR - Argentina 54
ZA - Sudafrica 50
FI - Finlandia 45
JP - Giappone 42
CH - Svizzera 37
ID - Indonesia 30
CI - Costa d'Avorio 28
ES - Italia 26
SC - Seychelles 24
BG - Bulgaria 18
CA - Canada 17
UA - Ucraina 17
BD - Bangladesh 16
BE - Belgio 14
PL - Polonia 13
AU - Australia 12
EC - Ecuador 12
MX - Messico 10
IQ - Iraq 9
RO - Romania 9
TR - Turchia 9
CO - Colombia 8
IL - Israele 8
JO - Giordania 8
PK - Pakistan 8
CL - Cile 7
AE - Emirati Arabi Uniti 5
GR - Grecia 5
LB - Libano 5
MY - Malesia 5
IR - Iran 4
PE - Perù 4
UZ - Uzbekistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EE - Estonia 3
ET - Etiopia 3
KE - Kenya 3
KG - Kirghizistan 3
MD - Moldavia 3
PY - Paraguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BZ - Belize 2
CR - Costa Rica 2
CU - Cuba 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LT - Lituania 2
MA - Marocco 2
PA - Panama 2
SA - Arabia Saudita 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
ME - Montenegro 1
MG - Madagascar 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 14.171
Salva come PNG Salva come JPEG
Città #
Singapore 1.156
Hong Kong 697
Chandler 693
Ashburn 504
Santa Clara 440
Southend 434
Fairfield 395
Hefei 338
Princeton 278
Wilmington 240
Dong Ket 239
Woodbridge 230
Houston 228
Beijing 201
Boardman 189
Seattle 188
Seoul 173
Dublin 164
Ann Arbor 160
Cambridge 141
Ho Chi Minh City 136
Hanoi 133
Lomé 108
Berlin 105
Westminster 99
Dallas 84
Des Moines 81
Los Angeles 74
Redondo Beach 64
Nuremberg 60
Jinan 54
Bologna 48
Buffalo 48
London 47
Milan 45
New York 44
Kerkrade 38
Bengaluru 35
Falls Church 33
San Diego 32
Yubileyny 32
Helsinki 31
Bern 30
Pune 29
Abidjan 28
Chicago 28
Tokyo 28
Vienna 28
São Paulo 27
Jakarta 25
Shanghai 24
Changsha 21
Nanjing 21
Shenzhen 21
Zhengzhou 21
Phoenix 20
Redwood City 19
Antioch 18
Frankfurt am Main 17
Sofia 17
Haiphong 16
Medford 16
Munich 16
Orlando 16
Hangzhou 15
Paris 15
Rochester 15
Taiyuan 15
Barcelona 14
Bühl 14
Quận Bình Thạnh 14
Brussels 13
Columbus 13
Naples 13
Norwalk 13
Tongling 13
Mülheim 12
Fuzhou 10
Indianapolis 10
Melbourne 10
Rome 10
San Jose 10
Wenzhou 10
Chennai 9
Da Nang 9
Guangzhou 9
Hải Dương 9
Las Vegas 9
Redmond 9
Shenyang 9
Amman 8
Amsterdam 8
Biên Hòa 8
Can Tho 8
Olalla 8
Rio de Janeiro 8
Saint Petersburg 8
Tianjin 8
Turku 8
Wuhan 8
Totale 9.387
Salva come PNG Salva come JPEG
Nome #
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 248
Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre 212
A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma 178
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 166
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial 165
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance) 162
24-Year-Old Woman with Recent Onset Back Pain 161
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT 151
Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients 150
2016 updates to the WHO brain tumor classification system: What the radiologist needs to know 144
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas 142
Heterogeneity within the PF-EPN-B ependymoma subgroup 138
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma 131
Failure of human rhombic lip differentiation underlies medulloblastoma formation 128
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading 124
Comparison on epidemiology, tumor location, histology, and prognosis of intracranial germ cell tumors between Mayo Clinic and Japanese consortium cohorts 123
Primary central nervous system vasculitis associated with lymphoma 120
Advances in multidisciplinary therapy for meningiomas 120
Rare primary non-neuroendocrine tumours of the sella 119
A 21-year-old woman with multiple cancers and a new brain lesion 118
Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia 114
The transcriptional landscape of Shh medulloblastoma 113
International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading 113
Anaplastic Ependymoma and Posterior Fossa Grouping in a Patient With H3K27ME3 Loss of Expression but Chromosomal Imbalance 112
Chordoma of the corpus callosum: Case report 112
Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration 110
A Comprehensive Study of Spindle Cell Oncocytoma of the Pituitary Gland: Series of 6 Cases and Meta-Analysis of 85 Cases 110
A tribute to our case of the month and a warm welcome to "under your microscope" 108
Adult patients with supratentorial pilocytic astrocytoma: Long-term follow-up of ospective multicenter clinical trial NCCTG-867251 (alliance) 108
Primary central nervous system vasculitis mimicking brain tumor: Comprehensive analysis of 13 cases from a single institutional cohort of 191 cases 108
Intertumoral Heterogeneity within Medulloblastoma Subgroups 108
Inflammatory cortical demyelination in early multiple sclerosis 107
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility 107
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13 107
Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas 106
Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis 106
Roles of Tumor Markers in Central Nervous System Germ Cell Tumors Revisited with Histopathology-Proven Cases in a Large International Cohort 105
Plenty of calcification: imaging characterization of polymorphous low-grade neuroepithelial tumor of the young 105
Life after surgical resection of a meningioma: A prospective cross-sectional study evaluating health-related quality of life 104
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma 104
Diagnostic and Therapeutic Strategy in Anaplastic (Malignant) Meningioma, CNS WHO Grade 3 104
Adult Medulloblastoma: Updates on Current Management and Future Perspectives 103
FGFR1:TACC1 fusion is a frequent event in molecularly defined extraventricular neurocytoma 103
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis 103
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations 102
Telomere alterations in neurofibromatosis type 1-associated solid tumors 102
A pediatric intra-axial malignant smarcb1-deficient desmo-plastic tumor arising in meningioangiomatosis 102
Imaging Findings of Cerebral Amyloid Angiopathy, Aβ-Related Angiitis (ABRA), and Cerebral Amyloid Angiopathy-Related Inflammation 102
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC) 100
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas 100
Frequency of false-positive FISH 1p/19q codeletion in adult diffuse astrocytic gliomas 99
Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature 99
Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it? 98
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872 98
Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors 98
Glioblastoma of the cerebellopontine angle and internal auditory canal mimicking a peripheral nerve sheath tumor: Case report 97
The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma 97
Bilateral generalized polymicrogyria (BGP) - A distinct syndrome of cortical malformation 96
SeekFusion - A Clinically Validated Fusion Transcript Detection Pipeline for PCR-Based Next-Generation Sequencing of RNA 95
Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation 95
Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior 95
Imaging and diagnostic advances for intracranial meningiomas 95
Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma 94
Subependymal giant cell astrocytoma-like astrocytoma: a neoplasm with a distinct phenotype and frequent neurofibromatosis type-1-association 93
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG) 93
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis 93
Low-grade fibromyxoid sarcoma arising within the median nerve 92
Molecular and translational advances in meningiomas 91
Glioneuronal Heterotopia Presenting as Cerebellopontine Angle Tumor of Cranial Nerve VIII 90
Case-based review: Primary central nervous system lymphoma 90
DNA methylation profiling to predict recurrence risk in meningioma: Development and validation of a nomogram to optimize clinical management 90
An Update of the Mayo Clinic Cohort of Patients with Adult Primary Central Nervous System Vasculitis 90
Adult primary central nervous system vasculitis treatment and course: Analysis of one hundred sixty-three patients 90
Primary papillary epithelial tumour of the sella: expanding the spectrum of TTF-1-positive sellar lesions 90
Venous congestive myelopathy: a mimic of neoplasia 89
Intracranial myxoid mesenchymal tumors with EWSR1–CREB family gene fusions: myxoid variant of angiomatoid fibrous histiocytoma or novel entity? 88
MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism 88
Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients 88
Can intraneural perineuriomas occur intradurally? An anatomic perspective 87
Case-based review: Newly diagnosed glioblastoma 87
Genomic and phenotypic characterization of a broad panel of patient-derived xenografts reflects the diversity of glioblastoma 87
Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience 87
PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases 85
Molecular profiling of long-term IDH-wildtype glioblastoma survivors 85
Brachial plexus lipomatosis with perineurial pseudoonion bulb formation: Result of a mosaic PIK3CA mutation in the para???axial mesoderm state 84
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant 84
Cavernous Hemangiomas of the Internal Auditory Canal and Cerebellopontine Angle 84
Ewing Sarcoma in Older Adults: A Clinicopathologic Study of 50 Cases Occurring in Patients Aged ≥40 Years, With Emphasis on Histologic Mimics 84
The dangers of the “Head Down” position in patients with untreated pituitary macroadenomas: case series and review of literature 83
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme 83
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572 83
Constitutive interferon pathway activation in tumors as an efficacy determinant following oncolytic virotherapy 81
Adenoid Cystic Carcinoma Metastatic to the Pituitary: A Case Report and Discussion of Potential Diagnostic Value of Magnetic Resonance Elastography in Pituitary Tumors 81
A revised diagnostic classification of canine glioma: Towards validation of the canine glioma patient as a naturally occurring preclinical model for human glioma 80
Pilocytic astrocytoma: pathology, molecular mechanisms and markers 79
Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis 79
The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients 78
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma 77
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas 76
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data 76
Totale 10.609
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.047 0 0 0 0 0 147 185 93 86 60 42 434
2021/20221.880 118 18 130 24 258 120 49 201 105 228 257 372
2022/20232.529 306 441 115 274 199 174 81 162 331 108 155 183
2023/2024600 41 133 36 36 66 87 49 35 20 39 44 14
2024/20253.344 52 467 230 262 659 175 227 86 55 112 156 863
2025/20263.677 465 769 760 425 754 504 0 0 0 0 0 0
Totale 14.568